The Trastuzumab antibody targets and destroys cancer cells that are HER2-positive.
Trastuzumab, also known by the brand name Herceptin,
is usually used after chemotherapy.
If your cancer is HER2 negative, then Trastuzumab will not be of any benefit.
Among them, rituximab, Trastuzumab, bevacizumab is a heavy product with a sales
of $ 7 billion;
Drugs like Trastuzumab(Herceptin) target this protein and can
slow or stop the growth of the cancer.
Ado-Trastuzumab may be an option for
women with metastatic breast cancer who have already tried Trastuzumab and chemotherapy.
Data: Top sellers TOP10 accounted for 3 seats,
rituximab, Trastuzumab, bevacizumab three drug sales totaling more
than 200 billion dollars.
Trastuzumab was included in the WHO Essential Medicines List
in 2015 as an essential treatment for about 20% of breast cancers.
If you need to take Trastuzumab, you will have regular tests on your heart
to make sure it's not causing any problems.
When the combination drug enters the body, the Trastuzumab helps it find the cancer cells because it is attracted to HER2.
Your doctor may
check your heart function before you may take any Trastuzumab and will monitor your heart closely during your treatment.
If you need to take Trastuzumab, you will need to have regular tests
on your heart to ensure it is not causing any problems.